Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Halozyme
Sort By
Newest First
1 / 1
1 / 1
Financing
Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx for ENHANZE
Halozyme Therapeutics
PR-09-24-NI-31
Oct 04, 2024
Collaboration
ViiV Healthcare and Halozyme Enter Global Collaboration for ENHANZE® Drug Delivery Technology to Enable Development of “Ultra Long-Acting” Medicines for HIV
GSK
PR-M06-21-032
Jun 25, 2021
Restructuring
Halozyme Announces Actions To Focus Strategy On ENHANZE® Drug Delivery Technology
Halozyme Therapeutics
PR-M11-19-NI-009-1975
Nov 08, 2019
Licensing
argenx Licenses Halozyme Subcutaneous Delivery Tech
Nice Insight
PAO-M02-19-NI-002
Feb 05, 2019
Clinical Trials
Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ENHANZE® Technology
Halozyme Therapeutics
PR-M07-18-NI-106
Jul 31, 2018
